Osimertinib for the Treatment of EGFR Mutation-Positive Lung Adenocarcinoma Complicated With Dermatomyositis Masahiro Yamasaki, Naoko Matsumoto, Shota Nakano, Kazuma Kawamoto, Masaya Taniwaki, Yusuke Izumi, Masaya Otohara, Shinji Nabeshima, Nobuyuki Ohashi, Noboru Hattori

Acquired T790M-positive Squamous Cell Lung Carcinoma that Responded to Osimertinib Masahiro Yamasaki, Kunihiko Funaishi, Wakako Daido, Noboru Hattori

Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population Filipa Aguiar, Gabriela Fernandes, Henrique Queiroga, José Carlos Machado, Luís Cirnes, Conceição Souto Moura, Venceslau Hespanhol